Modern approaches to evaluating the effectiveness of treatment of chronic heart failure

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access


The efficacy of therapy for patients with chronic heart failure, a new combination drug valsartan/sacubitrile according to the levels of biomarkers ST2 and NT-proBNP was evaluated. In all patients of the study group, valsartan/sacubitrile therapy improved the NYHA functional class, in the control group - only in 75%. The dynamics of indicators of biomarkers ST2 and NT-proBNP coincided with the improvement of the clinical status of patients against the background of therapy, and to a greater extent this trend reflects the indicator NT-proBNP.

Full Text

Restricted Access


Copyright (c) 2019 Eco-Vector

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies